Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. (Q36864992)
Jump to navigation
Jump to search
scientific article published on April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. |
scientific article published on April 2013 |
Statements
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis (English)
T Dirschka
P Radny
R Dominicus
H Mensing
H Brüning
L Jenne
L Karl
M Sebastian
C Oster-Schmidt
W Klövekorn
U Reinhold
M Tanner
D Gröne
M Deichmann
M Simon
F Hübinger
G Krähn-Senftleben
F Borrosch
K Reich
C Berking
P Wolf
P Lehmann
M Moers-Carpi
H Hönigsmann
K Wernicke-Panten
S Hahn
G Pabst
D Voss
M Foguet
B Schmitz
H Lübbert
R-M Szeimies
AK-CT002 Study Group
AK-CT003 Study Group
1 April 2013
1 reference